| 12-Jun-2026 |
119.05 |
-1.71 {-1.4 %} |
V: 10,832,202 |
|
| MRK |
12-Jun-2026 |
Close: 119.05 |
-1.71 {-1.4 %} |
Volume: 10,832,202 |
|
|
|
|
|
|
|
|
27-May-2026
05-Sep-2025
29-Aug-2025
28-Jun-2019
|
|
|
|
|
|
MRK
|
SPY
|
|
-1.4
-1.4
0.3
-1.0
13.1
|
0.5
0.6
-1.9
14.1
8.8
|
|
% Price Gain
WTD Performance (%)
MTD Performance (%)
QTD Performance (%)
YTD Performance (%)
|
SPY tracks S&P 500 index.
|
|
15 minute intraday candlestick chart, ~15 minute delay
15 minute intraday candlestick chart, ~15 minute delay
|
| MRK News | 12-Jun-2026 - Yahoo Finance
Merck (MRK) Stock After 53% One-Year Gain Is DCF Signaling Further Upside Potential
For investors considering whether Merck at around US$120.76 still offers value or whether most of the upside is already ... | 12-Jun-2026 - Seeking Alpha
Merck wins FDA label expansion for Welireg in kidney cancer
Merck (MRK) stock is in focus as the FDA approves a label expansion for the company's kidney cancer drug Welireg with its ... | 11-Jun-2026 - Yahoo Finance
Merck TARGAN Deal Highlights Poultry Tech Push And Undervalued Share Price
Merck Animal Health has agreed to acquire TARGAN, a biodevice company focused on poultry solutions. The deal adds automated, ... | 10-Jun-2026 - Yahoo Finance
Top Research Reports for Merck, Southern Company & Lumentum
Merck, Southern Company and Lumentum lead Zacks' featured research reports as growth drivers, expansion plans and key risks ... | 10-Jun-2026 - Yahoo Finance
Merck Stock Moves Above 50-Day SMA: Assessing Its Investment Case
MRK has reclaimed its 50-day SMA while holding above its 200-day trendline, backed by Keytruda growth, pipeline advances and ... | 9-Jun-2026 - Zacks
Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study
Gilead Sciences, Inc. GILD and partner Merck MRK announced positive data from two late-stage studies, ISLEND-1 and ISLEND-2, ... | 9-Jun-2026 - MSN
Gilead and Merck end Trodelvy-Keytruda lung cancer trial
On Monday, Gilead Sciences Inc. GILD and Merck & Co. Inc. MRK on Monday discontinued the Phase 3 KEYNOTE-D46/EVOKE-03 trial ... | 8-Jun-2026 - Yahoo
Merck (MRK) Explores Treatment Options for Rare Ebola Strain, Reuters Reports
Merck & Co., Inc. (NYSE:MRK) is included among the Billionaire Ken Fisher’s Top 11 Dividend Stock Picks. Reuters reported on ... | 7-Jun-2026 - The Globe and Mail
Zacks Investment Ideas feature highlights: Eli Lilly and Merck
Chicago, IL – June 8, 2026 – Today, Zacks Investment Ideas feature highlights Eli Lilly LLY and Merck MRK. There's an old ... | | | |
|
Latest MRK Trades by Congress Members
|
4-FEB-2026 - Josh Gottheimer, NJ (District 5) purchased between $1,001 and $15,000.
THIS TRADE WAS FILED 16-MAR-2026.
|
19-DEC-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.
THIS TRADE WAS FILED 12-JAN-2026.
|
18-DEC-2025 - Julie Johnson, TX (District 32) sold between $1,001 and $15,000.
THIS TRADE WAS FILED 15-JAN-2026.
|
18-NOV-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.
THIS TRADE WAS FILED 15-DEC-2025.
|
13-NOV-2025 - Julie Johnson, TX (District 32) sold some (partial sale) valued between $1,001 and $15,000.
THIS TRADE WAS FILED 11-DEC-2025.
|
|
Latest MRK Trades by Congress Members
|
4-FEB-2026 - Josh Gottheimer, NJ (District 5) purchased between $1,001 and $15,000.
THIS TRADE WAS FILED 16-MAR-2026.
|
19-DEC-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.
THIS TRADE WAS FILED 12-JAN-2026.
|
18-DEC-2025 - Julie Johnson, TX (District 32) sold between $1,001 and $15,000.
THIS TRADE WAS FILED 15-JAN-2026.
|
18-NOV-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.
THIS TRADE WAS FILED 15-DEC-2025.
|
13-NOV-2025 - Julie Johnson, TX (District 32) sold some (partial sale) valued between $1,001 and $15,000.
THIS TRADE WAS FILED 11-DEC-2025.
|
|
|
|
Disclaimer
Privacy
Contact
Copyright © 2001-2026, All rights reserved.
HotCandlestick.com, LLC
|
